Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
Finance & markets
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
National Trade News capital-markets note (2026-10-13): Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim. Primary source: original at CNBC Top News (cnbc.com).